Biocatalytic cascade to DMT derivatives

Biocatalytic cascade to DMT derivatives
Product Description

We developed and patented a combination of enzymes to access N,N-dimethyltryptamine and its derivatives (5-MeO DMT, psilocybin, psilocin, triptans). We look for strategic partnerships to advance the development of this bioprocess. 

Enzyan Biocatalysis GmbH

  • Country/Region:
    Austria
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Start-up
Primary activities
Agrochemical
Chemical Development
Contract Research Organisation
Fine Chemicals Company
Technology
Specifications
  • Selling Points
    Sustainability
  • Model
    Bioprocess

Enzyan Biocatalysis GmbH

  • Country/Region:
    Austria
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Start-up
Primary activities
Agrochemical
Chemical Development
Contract Research Organisation
Fine Chemicals Company
Technology

Enzyan Biocatalysis GmbH resources (4)